Dynamics of immune checkpoints, immune system, and BCG in the treatment of superficial bladder cancer (Q1784129)
From MaRDI portal
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Dynamics of immune checkpoints, immune system, and BCG in the treatment of superficial bladder cancer |
scientific article |
Statements
Dynamics of immune checkpoints, immune system, and BCG in the treatment of superficial bladder cancer (English)
0 references
26 September 2018
0 references
Summary: This paper aims to study the dynamics of immune suppressors/checkpoints, immune system, and BCG in the treatment of superficial bladder cancer. Programmed cell death protein-1 (PD-1), cytotoxic T-lymphocyte-associated antigen 4 (CTLA4), and transforming growth factor-beta (TGF-\(\beta\)) are some of the examples of immune suppressors/checkpoints. They are responsible for deactivating the immune system and enhancing immunological tolerance. Moreover, they categorically downregulate and suppress the immune system by preventing and blocking the activation of T-cells, which in turn decreases autoimmunity and enhances self-tolerance. In cancer immunotherapy, the immune checkpoints/suppressors prevent and block the immune cells from attacking, spreading, and killing the cancer cells, which leads to cancer growth and development. We formulate a mathematical model that studies three possible dynamics of the treatment and establish the effects of the immune checkpoints on the immune system and the treatment at large. Although the effect cannot be seen explicitly in the analysis of the model, we show it by numerical simulations.
0 references
immune checkpoints
0 references
immune system
0 references
superficial bladder cancer
0 references
programmed cell death protein-1
0 references
transforming growth factor-beta
0 references
cancer immunotherapy
0 references
0 references